Boston Globe Life Sciences Media: STAT
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
Researchers aim identify the root causes of drug-induced diabetes among cancer patients, and then to develop new therapeutic strategies for preventing diabetic complications.
Transplant surgeons at two US hospitals are about to do something long considered taboo: put kidneys from donors with hepatitis C into recipients without the infection.
The intellectual property is secure. The science is sound. You’re about to make your pitch for funding. The scary next step for a biotech entrepreneur? Picking a company name.
A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.